PumaRx Registry Trial

Part of paid clinical trials in Coral Gables, Florida.

Sponsor
RenovoRx
Study ID
NCT06805461
Status
Recruiting
Apply to this trial

Conditions

  • Solid Tumors

Eligibility Criteria

Sex
ALL
Age
18 Years - N/A
Healthy Volunteers
Not accepted

Interventions

  • RenovoCath® — DEVICE
    Intra-arterial catheter delivery of chemotherapy agents for the collection of real-world data.

Study Details

This study is a multicenter, observational, post-marketing, registry study designed to track the safety and performance of the RenovoCath® device and assess survival outcomes in patients diagnosed with solid tumors who are treated with localized intra-arterial (IA) delivery of therapeutic agents to solid tumors using the RenovoCath® catheter.

Key Dates

Start date
Aug 1, 2025
Status verified
Oct 2025
Primary completion
Sep 3, 2029
Completion
Sep 3, 2029

Study Design

Enrollment
1,000 participants (estimated)

Arms

  • Arm: Patients receiving Intra-Arterial treatment with RenovoCath
    Patients receiving Intra-Arterial treatment with RenovoCath

Primary Outcome Measure

Safety of RenovoCath® as assessed by the number of participants experiencing adverse events related to the chemotherapy agents administered using RenovoCath. [ Time Frame: From the time of the first treatment, until 30 days after the last treatment ]

Central Contacts

Locations (3)

FacilityCityStateZIPSite coordinators
Baptist Health South FloridaCoral GablesFlorida33143
Dr. Gandhi
University of Pennsylvania Medical CenterPittsburghPennsylvania15213
Dr. Novelli
The University of Vermont Medical CenterBurlingtonVermont05401
Dr. O'Neill

Find similar trials in Coral Gables, FL

By research site
Baptist Health South Florida· Coral Gables, FLUniversity of Pennsylvania Medical Center· Pittsburgh, PAThe University of Vermont Medical Center· Burlington, VT

Related Studies